WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

*Meenu Sharma and Dr. Sachin Rastogi

ABSTRACT

The Research topic under the caption aims at its own essence especially dealing with Pharmaceutical Companies, their products and operation within the Indian territories whether as Foreign Company and/or Indigent incorporated legal entity. A general ascertainment of such companies places them at a figure more than 10563 as up to 2020 out of total active companies including other than pharma companies in India standing at 1,19,5045 The Pharmaceutical Companies are located in different Indian state with highest number in Maharashtra being 3139 Most of the states do not show the presence of said companies in their geographical areas. In India the top of the Pharmaceutical Companies still are non-indigent like Johnson and Johnson with 56.1 bn US$ , Pfizer with 51.75bn US$, Roche at 49.23 bn US$, Novartis with 47.45 bn US$ and at fifth one finds Merch &Co having 46.84bn US$ as capital adequacy. All these companies in addition to other Regulatory Mechanism fall within the Regulatory mechanism of Indian laws including that provided under the Companies Act as far the Incorporation is concerned and for manufacturing, sale and like other activities they come under the Drugs and Pharmaceutical Companies Act,1940.The Regulatory system covers the compliances for various laws including those under respective States where the Pharmaceutical Company(s) is Registered, established and/or operating in a way India reflects multiple Regulators with divergent approach .The analysis and deliberations are based on doctrinal methodology based on both primary and secondary source of data for answer to Research question with respect to diverse Regulatory mechanism and its effectiveness in achieving the objective.

[Full Text Article] [Download Certificate]